Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

: Therapeutic-dose anticoagulation with heparin - JSON Representation

Active as of 2022-08-05

Raw json | Download

{
  "resourceType" : "EvidenceVariable",
  "id" : "7751",
  "meta" : {
    "versionId" : "13",
    "lastUpdated" : "2024-11-19T17:01:54.513Z"
  },
  "text" : {
    "status" : "empty",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"
  },
  "url" : "https://fevir.net/resources/EvidenceVariable/7751",
  "identifier" : [
    {
      "type" : {
        "coding" : [
          {
            "system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
            "code" : "ACSN",
            "display" : "Accession ID"
          }
        ],
        "text" : "FEvIR Object Identifier"
      },
      "system" : "urn:ietf:rfc:3986",
      "value" : "https://fevir.net/FOI/7751",
      "assigner" : {
        "display" : "Computable Publishing LLC"
      }
    },
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113883.4.642.40.44.24.55"
    }
  ],
  "version" : "2.0.0-ballot",
  "name" : "Therapeutic_dose_anticoagulation_with_heparin",
  "title" : "Therapeutic-dose anticoagulation with heparin",
  "status" : "active",
  "date" : "2022-08-05T14:37:53.832Z",
  "publisher" : "HL7 International / Clinical Decision Support",
  "contact" : [
    {
      "name" : "HL7 International / Clinical Decision Support",
      "telecom" : [
        {
          "system" : "url",
          "value" : "http://www.hl7.org/Special/committees/dss"
        }
      ]
    }
  ],
  "description" : "Therapeutic-dose anticoagulation with unfractionated or low-molecular-weight heparin was administered according to local protocols for the treatment of acute venous thromboembolism for up to 14 days or until recovery; the latter was defined as hospital discharge or a discontinuation of supplemental oxygen for at least 24 hours.",
  "copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/",
  "author" : [
    {
      "name" : "Brian S. Alper"
    }
  ],
  "relatedArtifact" : [
    {
      "type" : "cite-as",
      "citation" : "Therapeutic-dose anticoagulation with heparin [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 7751. Revised 2022-08-05. Available at: https://fevir.net/resources/EvidenceVariable/7751. Computable resource at: https://fevir.net/resources/EvidenceVariable/7751."
    }
  ]
}